Access cutting-edge pulmonary hypertension treatment through this clinical trial at a research site in Louisville. Study-provided care at no cost to qualified participants.
Access pulmonary hypertension specialists in Louisville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary hypertension treatment provided free
This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Sponsor: Pulmovant, Inc.
Check if you qualify for this pulmonary hypertension clinical trial in Louisville, KY
If you're searching for pulmonary hypertension treatment options in Louisville, KY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Louisville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.